Goldman Sachs Group Inc Biotech Acquisition CO Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

Shares

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 May 14, 2024	BUY	$8.96 - $9.97 $2.08 Million - $2.32 Million	232,325 New	232,325 $2.3 Million
Q2 2022 Aug 15, 2022	SELL	$8.96 - $9.97 $8,064 - $8,973	-900 Reduced 0.39%	232,325 $2.3 Million
Q4 2021 Feb 14, 2022	SELL	$9.73 - $9.91 $11,617 - $11,832	-1,194 Reduced 0.51%	233,225 $2.3 Million
Q3 2021 Nov 10, 2021	BUY	$9.64 - $9.75 $2.26 Million - $2.29 Million	234,419 New	234,419 $2.28 Million

Others Institutions Holding BIOT

# of Institutions

1

Shares Held

0

Call Options Held

0

Put Options Held

0

Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

About Biotech Acquisition Co

Ticker BIOT
Exchange NASDAQ
Sector Financial Services
Industry Shell Companies
Shares Outstandng 23,000,000
Description
Biotech Acquisition Company does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.

More about BIOT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.